BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 8994831)

  • 1. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells.
    Stambolic V; Ruel L; Woodgett JR
    Curr Biol; 1996 Dec; 6(12):1664-8. PubMed ID: 8994831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wingless inactivates glycogen synthase kinase-3 via an intracellular signalling pathway which involves a protein kinase C.
    Cook D; Fry MJ; Hughes K; Sumathipala R; Woodgett JR; Dale TC
    EMBO J; 1996 Sep; 15(17):4526-36. PubMed ID: 8887544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Wnt signaling pathway: a molecular mechanism for lithium action.
    Hedgepeth CM; Conrad LJ; Zhang J; Huang HC; Lee VM; Klein PS
    Dev Biol; 1997 May; 185(1):82-91. PubMed ID: 9169052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New steps in the Wnt/beta-catenin signal transduction pathway.
    Sakanaka C; Sun TQ; Williams LT
    Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
    Chen RH; Ding WV; McCormick F
    J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons.
    Takahashi M; Yasutake K; Tomizawa K
    J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
    Lochhead PA; Coghlan M; Rice SQ; Sutherland C
    Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSK-3beta negatively regulates skeletal myotube hypertrophy.
    Vyas DR; Spangenburg EE; Abraha TW; Childs TE; Booth FW
    Am J Physiol Cell Physiol; 2002 Aug; 283(2):C545-51. PubMed ID: 12107064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium.
    Ryves WJ; Harwood AJ
    Biochem Biophys Res Commun; 2001 Jan; 280(3):720-5. PubMed ID: 11162580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells.
    Lovestone S; Reynolds CH; Latimer D; Davis DR; Anderton BH; Gallo JM; Hanger D; Mulot S; Marquardt B; Stabel S
    Curr Biol; 1994 Dec; 4(12):1077-86. PubMed ID: 7704571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.
    Fang X; Yu SX; Lu Y; Bast RC; Woodgett JR; Mills GB
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11960-5. PubMed ID: 11035810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GSK-3: new thoughts on an old enzyme.
    Ferkey DM; Kimelman D
    Dev Biol; 2000 Sep; 225(2):471-9. PubMed ID: 10985864
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
    Liu C; Li Y; Semenov M; Han C; Baeg GH; Tan Y; Zhang Z; Lin X; He X
    Cell; 2002 Mar; 108(6):837-47. PubMed ID: 11955436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR; Scheid MP; Santos L; Dang-Lawson M; Roth RA; Matsuuchi L; Duronio V; Krebs DL
    J Immunol; 1999 Aug; 163(4):1894-905. PubMed ID: 10438924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B.
    Cross DA; Alessi DR; Cohen P; Andjelkovich M; Hemmings BA
    Nature; 1995 Dec 21-28; 378(6559):785-9. PubMed ID: 8524413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycogen synthase kinase-3 inhibition by lithium and beryllium suggests the presence of two magnesium binding sites.
    Ryves WJ; Dajani R; Pearl L; Harwood AJ
    Biochem Biophys Res Commun; 2002 Jan; 290(3):967-72. PubMed ID: 11798168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt-1 dependent activation of the survival factor NF-kappaB in PC12 cells.
    Bournat JC; Brown AM; Soler AP
    J Neurosci Res; 2000 Jul; 61(1):21-32. PubMed ID: 10861796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster.
    Papadopoulou D; Bianchi MW; Bourouis M
    Mol Cell Biol; 2004 Jun; 24(11):4909-19. PubMed ID: 15143183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A molecular mechanism for the effect of lithium on development.
    Klein PS; Melton DA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8455-9. PubMed ID: 8710892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.